These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 13980982)

  • 1. [Therapeutic application of an inhibitor of histidine-decarboxylase].
    THIERS H; MOULIN G; ROUHANI A
    Lyon Med; 1963 Mar; 209():689-94. PubMed ID: 13980982
    [No Abstract]   [Full Text] [Related]  

  • 2. [Considerations on the histidine-decarboxylase inhibitor (554 L) in the treatment of pruriginous disease].
    Abry M
    Lyon Med; 1967 Mar; 217(10):753-6. PubMed ID: 4387192
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of histidine decarboxylase inhibitor 554 L (Hypostamine) on the behavior of certain indices of histamine and serotonin metabolism].
    Czernielewski A; Pakszys W; Wranicz A; Matyjewska H
    Przegl Dermatol; 1967; 54(1):17-22. PubMed ID: 4382888
    [No Abstract]   [Full Text] [Related]  

  • 4. [New derivatives with presumed histidine decarboxylase inhibitory action].
    Giannini M; Fedi M
    Boll Chim Farm; 1970 Jan; 109(1):39-47. PubMed ID: 4393826
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of adjuvant arthritis in rats with the histidine decarboxylase inhibitor hypostamine.
    Pelczarska A
    J Pharm Pharmacol; 1969 Oct; 21(10):692-3. PubMed ID: 4390614
    [No Abstract]   [Full Text] [Related]  

  • 6. [Histidine decarboxylase inhibitors].
    Kasztreiner E; Szilágyi G; Szakályné KJ; Huszti Z; Kürti M
    Acta Pharm Hung; 1973 Jul; 43(3):121-5. PubMed ID: 4127039
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic effects of an antihistadine decarboxylase and antihistamine combination.
    SCHULTZ J
    Ann Allergy; 1951; 9(1):15-8. PubMed ID: 14800186
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic application of a histidine decarboxylase inhibitor (554 L) in otorhinolaryngologic allergies].
    Mounier-Kuhn P; Gaillard J; Fontvielle J
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1968 May; 17(5):449-56. PubMed ID: 4386660
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of the action of a histidine-decarboxylase inhibitor (L 554) on various allergic manifestations].
    CASTELAIN PY
    Mars Med; 1963; 100():121-9. PubMed ID: 14019175
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical observations on the effectiveness of a combination of an antihistadine decarboxylase and an antihistamine; preliminary report.
    CHUNN L
    Ann Allergy; 1951; 9(1):11-4; passim. PubMed ID: 14800185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biological study of the effects of a histidine decarboxylase inhibitor (L 554) on histidine metabolism].
    Cotte J; Collombel C; Carron R
    Pediatrie; 1966; 21(7):841-3. PubMed ID: 4382608
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of an inhibitor of histidine decarboxylase on the liberation and reconstitution of cutaneous histamine in rats].
    Grilliat JP; Laurent J; Noirel B; Arnould P
    Rev Fr Allergol; 1966; 6(2):84-92. PubMed ID: 4161301
    [No Abstract]   [Full Text] [Related]  

  • 13. Histamine excretion and dermographism in urticaria pigmentosa before and after administration of a specific histidine-decarboxylase inhibitor.
    Greaves MW
    Br J Dermatol; 1971 Nov; 85(5):467-70. PubMed ID: 4108905
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary clinical trials of a new histidine-decarboxylase inhibitor in the therapy of prurigo].
    Rossi A; De Luca M
    Arch Anat Microsc Morphol Exp; 1970; 59(2):201-4. PubMed ID: 4194817
    [No Abstract]   [Full Text] [Related]  

  • 15. [In vivo anihistidine-decarboxylasic activity of 2-methyl-6,7-methylendioxy-8-methoxy-1-(4', 5', 6',-triothoxy-7-aminophthalidyl)-1,2,3,4 tetrahydroisoquinoline (tritoqualine)].
    Carpi C; Maggi GC
    Boll Soc Ital Biol Sper; 1968 Mar; 44(6):543-6. PubMed ID: 5674876
    [No Abstract]   [Full Text] [Related]  

  • 16. Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist.
    Liu CQ; Hu DN; Liu FX; Chen Z; Luo JH
    Pharmacol Biochem Behav; 2008 Sep; 90(3):325-30. PubMed ID: 18452981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the occurrence of histidine decarboxylase in Salmonella strains of various serotypes].
    Scheibner G
    Z Gesamte Hyg; 1968 Mar; 14(3):204-6. PubMed ID: 5734011
    [No Abstract]   [Full Text] [Related]  

  • 18. Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice.
    Yoshida A; Mobarakeh JI; Sakurai E; Sakurada S; Orito T; Kuramasu A; Kato M; Yanai K
    Eur J Pharmacol; 2005 Oct; 522(1-3):55-62. PubMed ID: 16212954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of histaminergic neurons in development of epileptic seizures in EL mice.
    Yawata I; Tanaka K; Nakagawa Y; Watanabe Y; Murashima YL; Nakano K
    Brain Res Mol Brain Res; 2004 Dec; 132(1):13-7. PubMed ID: 15548424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparative isolation of crystalline histidine decarboxylase from Micrococcus sp. n].
    Prozorovskiĭ VN; Tartakovskiĭ SA; Alekseeva AE; Mardashev SR; Nikolaev AIa
    Biokhimiia; 1970; 35(4):759-62. PubMed ID: 5498657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.